Indoprofen
| Clinical data | |
|---|---|
| Routes of administration | Oral | 
| ATC code | |
| Legal status | |
| Legal status | 
 | 
| Pharmacokinetic data | |
| Bioavailability | High (rapid and complete absorption) | 
| Metabolism | Glucuronidation | 
| Elimination half-life | 2.3 hours | 
| Excretion | Renal | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.046.197 | 
| Chemical and physical data | |
| Formula | C17H15NO3 | 
| Molar mass | 281.311 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Indoprofen is a nonsteroidal anti-inflammatory drug (NSAID). It was withdrawn worldwide in the 1980s after postmarketing reports of severe gastrointestinal bleeding.
A 2004 study using high-throughput screening found indoprofen to increase production of the survival of motor neuron protein, suggesting it may provide insight into treatments for spinal muscular atrophies.